📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses (2022)

First Author: Murray S

Attributed to: MICA: ERADICATE HIV-1: TARGETING THE HIV-1 RESERVOIR WITH NEW IMMUNOTHERAPEUTIC STRATEGIES funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41577-022-00809-x

PubMed Identifier: 36539527

Publication URI: http://europepmc.org/abstract/MED/36539527

Type: Journal Article/Review

Parent Publication: Nature Reviews Immunology

Issue: 5

ISSN: 1474-1733